Abstract: BaCkground: To study the effective therapeutic concentration, drug application duration, irradiation duration and irradiation dosage of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) for treating vitiligo and observe its clinical efficacy. oBjeCtive: To assess the clinical efficacy of ALA-PDT for treating vitiligo. Methods: ALA with different drug concentrations, drug application durations, irradiation durations and irradiation dosages were adopted to treat skin lesions caused by vitiligo to determine the effective drug concentration, drug application duration, irradiation duration and irradiation dosage for treating three vitiligo volunteers and observe the therapeutic results. results: The clinical trial suggested that ALA at a drug concentration of 1.5%, drug application duration for 3 hours, irradiation dosage of 80mw/cm 2 and irradiation duration for 20 min was effective in treating vitiligo. Under these parameters, ALA-PDT was effective to the three vitiligo volunteers, with mild pain and feeling of burning but no other adverse reaction during treatment. study liMitations: Due to the small sample size in this study for the effectiveness of PDT in treating vitiligo and the potential variations in the efficacy for treating the disease at different areas, further studies shall be conducted for confirmation. ConClusions: ALA with a drug concentration at 1.5%, drug application duration for 3 hours, irradiation dosage of 80 mw/cm 2 and irradiation duration for 20 min is effective in treating vitiligo. Therefore, ALA-PDT is safe and effective in treating the disease, with minor adverse events, providing a new method for treating vitiligo in the future.
INTRODUCTION
Vitiligo is an acquired local or generalized skin depigmentation disorder with a morbidity of 0.5-2%. 1, 2 The disease is difficult to treat and involves a long course of therapy. Besides, patients with vitiligo receive different therapies and medicines based on their distinctive pathogenesis, triggering factors, clinical type, and conditions, with different curative effects. Our research group studied the effectiveness of the combination of 5-aminolevulinic acid and photodynamic therapy (ALA-PDT) in treating vitiligo, to observe the effective drug concentration, drug application duration, irradiation duration, and irradiation dosage. We treated three vitiligo volunteers with appropriate dosages, aiming to observe the clinical efficacy.
METHODS
The three vitiligo volunteers (two males and one female) included in this study were selected from the vitiligo patients diagnosed in our hospital's Dermatology Clinic, with age at onset between four and 28 years (mean 16 years) and course of disease between 2 and 10 years. Case 1, female, 27 years old, found a small white patch on her trunk with no obvious cause 18 years ago, which progressively grew into a large area and extended to the limbs, perineum, face and neck. According to her medical history, she was healthy, but her father had vitiligo on his hands. Case 2, male, 17 years old, found a small white patch on his abdomen with no obvious cause four years ago, which progressively grew into a larger area. He was previously healthy and had no family history of vitiligo. Case 3 was a male, four years old, whose parents found a small white patch on his forehead with no obvious cause two years previously, which progressively grew into an egg-size oval depigmentation patch and extended to the left eyebrow. He was previously healthy and had no family history of vitiligo. Figures 1A and 1B ).
The skin area was divided into 24 units. A piece of black plastic film was divided evenly into 24 grids and labeled as 24 treatment units.
The plastic films were attached to the skin area and labeled with numbers to prevent shifting ( Figure 1C ). ALA at different concentrations was applied to the corresponding treatment units according to the concentration requirements in table 1, and the area was covered to protect from light. Treatment was provided on the basis of preset drug application duration, irradiation duration, and irradiation dosage ( Table 1 and Figure 1D ). Skin reactions were observed immediately after the irradiation and at 24h after treatment.
Operation mode selection for PDT in vitiligo:
Effective therapeutic concentration, drug application duration, irradiation duration, and irradiation dosage were selected on the basis of the findings from the previous experiment. According to the above parameters, PDT was used to treat three cases. After applying a certain concentration of ALA on the patients' vitiliginous area for a specific period of time, we applied PDT based on preset irradiation duration and dosage, and then observed the treatment efficacy and reactions.
RESULTS
The experiment's findings for most effective treatment concentration:
Case 1 showed immediate and obvious reactions on the dorsum (areas 9, 10, 21, and 22), plus a burning sensation during treatment and erythema after treatment (Figure 2A ). At 48 hours post-treatment, areas 9, 17, 18, 21, and 22 showed post-treatment red papules around hair follicles ( Figure 2B ). On the basis of the reactions, the parameters for area 9 (ALA concentration 1.5%, drug application duration 3h, irradiation duration 20min, and irradiation dosage 80mw/cm 2 ) were selected as the effective parameters for treating the patients, and the therapeutic results were observed.
Efficacy of PDT in treating vitiligo
According to the experiment, ALA at a concentration of 1.5%, drug application duration 3h, irradiation dosage 80mw/cm, and irradiation duration 20min were safe and effective in treating vitiligo, with mild pain and burning sensation but no other adverse effects during treatment.
Efficacy in Case 1: Before treatment ( Figure 3A ). Perifollicular pigment islands were found on vitiliginous areas after the first three treatments at seven-day intervals and increased progressively days, respectively) in the eight months ( Figure 4E ). During the 75-day follow-up visit after discontinuance of treatment, no significant change was observed in the vitiliginous skin lesions compared to the condition after the previous treatment ( Figure 4F ).
Efficacy in Case 3: Before treatment ( Figure 5A ). Pigment islands were seen in the vitiliginous area near the left eyebrow after three treatments ( Figure 5B ). After 13 PDT sessions, pigment islands were observed first on the forehead ( Figure 5C ). From March 21, 2016, to June 27, 2016, after seven consecutive treatments at 10-14-day intervals, the pigment islands increased significantly on the skin lesion area near the hairline, as the total number of treatments increased ( Figure 5D ). Currently, PDT has achieved satisfactory efficacy in treating pediatric laryngeal papilloma, condyloma acuminatum, and acne. [9] [10] [11] [12] On the basis of the principle of PDT, photosensitization can be selectively enriched in virally infected foci after being applied locally on skin lesions. Under 635nm laser irradiation, it generates singlet oxygen and other active oxides, which can damage cell membranes, mitochondria, and DNA, cause cell necrosis and apoptosis, and then kill diseased cells. 12, 13 In recent years, some researchers have found that PDT shows efficacy by activating local specific immunity. 14, 15 Brotosik et al. found that PDT resulted in apoptosis of epidermal keratinocytes and Langerhans cells. 16 However, there have been no clinical studies to date on the clinical mechanism of PDT in vitiligo.
DISCUSSION
It is inferred that PDT has a therapeutic effect by participating in local specific immunity. Besides, He-Ne laser adopted by PDT is a type of low-energy laser, with a laser wavelength of 633±10nm. It can improve melanocytes' adhesiveness on IV-type collagens, inhibit their mobility, strengthen their migration on type-I collagens, and enhance expression of α2β1 integrins, so as to promote melanocytes' proliferation. 17 Byun et al. 18 ALA at a concentration at 1.5%, drug application for 3h, irradiation dosage of 80mw/cm 2 , and irradiation duration for 20 minutes was adopted to treat the three vitiligo patients. Perifollicular pigment islands were seen in vitiliginous areas after the first three treatments at seven-day intervals and increased with the number of treatments ( Figures 3B, 4B, and 5B). In case 1, from July 12, 2013, to 
